Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of a purified somatostatin monoclonal antibody,
SOMA
10, and its Fab fragments on
gastrin
release have been examined in the isolated perfused rat stomach.
SOMA
10 was purified from ascites fluid by ammonium sulfate precipitation followed by hydroxylapatite (HAP) chromatography. This gave a preparation of greater than 90% purity, as assessed by fast affinity and size exclusion high-performance liquid chromatography (HPLC). HAP-purified
SOMA
10 had a binding capacity of 760 mmol somatostatin/mol antibody, a dissociation constant of 2.2 nM, and recognized amino acid residues 5-12 of the somatostatin molecule. Fab fragments of
SOMA
10 were prepared and purified by protein A affinity chromatography, and the purity assessed by HPLC and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Single passage perfusion of
SOMA
10 (100 micrograms/ml) into the gastric vasculature caused a paradoxical decrease in basal
gastrin
release. However, recirculation of the antibody (20 micrograms/ml) caused an increase in cumulated
gastrin
release. Perfusion of Fab fragments of
SOMA
10 (66 micrograms/ml) also increased
gastrin
secretion. These results support the suggestion that somatostatin exerts a tonic restraint on
gastrin
release and that penetration of the antibody to the site of somatostatin release is necessary for it to have an effect.
...
PMID:Effect of a purified somatostatin monoclonal antibody and its Fab fragments on gastrin release. 170 49